Professor Kelly Chibale is the Neville Isdell Chair in African-centric Drug Discovery & Development and Professor of Organic Chemistry at the University of Cape Town (UCT). Chibale is the founding Director of the South African Medical Research Council (SAMRC) Drug Discovery & Development Research Unit at UCT and the Founder and Director of the UCT Drug Discovery and Development Centre (H3D) and is the Chairman and CEO of the H3D Foundation.

He is also a Full Member of the UCT Institute of Infectious Disease & Molecular Medicine and a Tier 1 South Africa Research Chair in Drug Discovery. In 2018 Professor Chibale was recognized by Fortune magazine as one of the World’s 50 Greatest Leaders and in 2019 he was named as one of the 100 Most Influential Africans by New African magazine.